Jeffrey Chan
  1. Associate
  1. Hong Kong
+852 2533 1022

Mr. Chan is an associate in Davis Polk’s Corporate Department, resident in Hong Kong.

Work Highlights

  • Tencent Holdings’ HK$550 million subscription of shares of China Youzan
  • Tencent Holdings’ HK$353 million purchase of shares of Weimob Inc.
  • Antengene's $357 million Hong Kong IPO and global offering 
  • JW Therapeutics' $300 million Hong Kong IPO and global offering
  • Ming Yuan Cloud's $797 million Hong Kong IPO and global offering
  • NetEase's $3.1 billion Hong Kong secondary listing
  • AssetMark Financial Holdings’ $316 million U.S. IPO and listing on the NYSE
  • AsiaInfo Technologies' $110.6 million Hong Kong IPO and global offering 
  • Hope Education Group's 389.7 million Hong Kong IPO and global offering
  • 51 Credit Card’s $130 million Hong Kong IPO and global offering 
  • Top-up placing of shares in Ronshine China

Professional History

  • Davis Polk since 2018

Practice Focus

Bar Admissions

  • Hong Kong

Education

  • LL.B., Newcastle University, 2011
  • PCLL, University of Hong Kong, 2014